| Oct 16 |
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience
|
| Oct 11 |
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs
|
| Oct 10 |
Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock
|
| Oct 9 |
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide
|
| Oct 7 |
Summit Hotel Properties, Inc. (INN) Hit a 52 Week High, Can the Run Continue?
|
| Oct 3 |
Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?
|
| Sep 11 |
SUMMIT HOTEL PROPERTIES PUBLISHES 2024 CORPORATE RESPONSIBILITY REPORT
|
| Aug 29 |
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
|
| Aug 12 |
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million
|
| Aug 2 |
Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)
|
